Affected Genome Editing Crops: The Consequences of Genome-Edited Babies in China

Though genome editing (GE) is a powerful technology, germline GE engineering is strongly objectionable for a huge ethical challenge. The after-effects of the genome-edited babies incident have been emerging in China, whether technology or ethics. It is very noticeable that the case has been adverse effects on the application of GE technology in other fields, especially in GE crops. After the incident, research and development of GE crops was affected obviously. It is clear that GE crops and other basic research and application related to GE technology should be encouraged and should not be treated differently. An ethically acceptable development route of GE technology needs to be established in China.

[1]  Dana Carroll,et al.  Genome editing: progress and challenges for medical applications , 2016, Genome Medicine.

[2]  Fredrik Lanner,et al.  Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos , 2017, Development.

[3]  Emily Waltz,et al.  Gene-edited CRISPR mushroom escapes US regulation , 2016, Nature.

[4]  Yanpeng Wang,et al.  CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture. , 2019, Annual review of plant biology.

[5]  Chinese Academy of Sciences,et al.  Gene-edited babies: Chinese Academy of Medical Sciences’ response and action , 2019, The Lancet.

[6]  Xiao Ying Zhang,et al.  The Challenges of Medical Ethics in China: Are Gene-Edited Babies Enough? , 2020, Sci. Eng. Ethics.

[7]  Henry T Greely,et al.  CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’ , 2019, Journal of law and the biosciences.

[8]  G. Schatten,et al.  Are we ready for genome editing in human embryos for clinical purposes? , 2019, European journal of medical genetics.

[9]  Jiayi Zhu,et al.  New Official Documents of China Addressing Academic Misconduct , 2020, Sci. Eng. Ethics.

[10]  Morgan L. Maeder,et al.  Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy. , 2015, Human gene therapy.

[11]  Dennis Normile,et al.  Shock greets claim of CRISPR-edited babies. , 2018, Science.

[12]  Yue Huang,et al.  The CRIPSR/Cas gene‐editing system—an immature but useful toolkit for experimental and clinical medicine , 2019, Animal models and experimental medicine.

[13]  Detlef Weigel,et al.  A proposed regulatory framework for genome-edited crops , 2016, Nature Genetics.

[14]  Rachel L Mintz,et al.  Will CRISPR Germline Engineering Close the Door to an Open Future? , 2018, Sci. Eng. Ethics.

[15]  Jian-Kang Zhu,et al.  Gene editing in plants: progress and challenges , 2019, National science review.

[16]  Dennis Normile,et al.  China tightens rules on gene editing. , 2019, Science.

[17]  Michael Morrison,et al.  CRISPR in context: towards a socially responsible debate on embryo editing , 2019, Palgrave Communications.